Augmentation index and the evolution of aortic disease in marfan-like syndromes

American Journal of Hypertension

Volumn 23, Issue 7, 2010, Pages 716-724

  Mortensen, Kai ^a   Baulmann, Johannes ^b   Rybczynski, Meike ^a   Sheikhzadeh, Sara ^a   Aydin, Muhammet A ^a   Treede, Henrik ^a   Dombrowski, Ellen ^a   Kühne, Kristin ^a   Peitsmeier, Philipp ^a   Habermann, Christian R ^a   Robinson, Peter N ^c   Stuhrmann, Manfred ^d   Berger, Jürgen ^a   Meinertz, Thomas ^a   Von Kodolitsch, Yskert ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Applanation tonometry; Augmentation index; Bicuspid aortic valve; Blood pressure; Hypertension; Loeys Dietz syndrome

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ADULT; AGED; AORTA DISEASE; AORTA DISSECTION; AORTA SURGERY; ARTICLE; AUGMENTATION INDEX; DISEASE COURSE; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANOMETER; MARFAN SYNDROME; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULSE PRESSURE; TONOMETRY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DISSECTING ANEURYSM; ECTOPIA LENTIS; HEMODYNAMICS; LOEYS DIETZ SYNDROME; MITRAL VALVE PROLAPSE; PATHOLOGY; PATHOPHYSIOLOGY; THORACIC AORTA ANEURYSM; YOUNG ADULT;

ADULT; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; AORTIC DISEASES; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DISEASE PROGRESSION; ECTOPIA LENTIS; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; LOEYS-DIETZ SYNDROME; MALE; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; YOUNG ADULT;

EID: 77953809258     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.78     Document Type: Article

References (36)

1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
2. Mortensen K, Aydin MA, Rybczynski M, Baulmann J, Schahidi NA, Kean G, Kühne K, Bernhardt AM, Franzen O, Mir T, Habermann C, Koschyk D, Ventura R, Willems S, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y. Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. Am J Hypertens 2009; 22:971-979.
3. Segers P, De Backer J, Devos D, Rabben SI, Gillebert TC, Van Bortel LM, De Sutter J, De Paepe A, Verdonck PR. Aortic reflection coefficients and their association with global indexes of wave reflection in healthy controls and patients with Marfan's syndrome. Am J Physiol Heart Circ Physiol 2006; 290:H2385-H2392.
4. Meijboom LJ, Westerhof BE, Nollen GJ, Spaan JA, de Mol BA, Jacobs MJ, Mulder BJ. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement. Eur J Cardiothorac Surg 2004; 26:901-906.
5. Payne RA, Hilling-Smith RC, Webb DJ, Maxwell SR, Denvir MA. Augmentation index assessed by applanation tonometry is elevated in Marfan Syndrome. J Cardiothorac Surg 2007; 2:43.
6. Payne RA. Augmenting the assessment of Marfan syndrome? Am J Hypertens 2009; 22:951.
7. von Kodolitsch Y, Robinson PN. Marfan syndrome: an update of genetics, medical and surgical management. Heart 2007; 93:755-760.
8. Rybczynski M, Bernhardt AM, Rehder U, Fuisting B, Meiss L, Voss U, Habermann C, Detter C, Robinson PN, Arslan-Kirchner M, Schmidtke J, Mir TS, Berger J, Meinertz T, von Kodolitsch Y. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A 2008; 146A:3157-3166.
9. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355:788-798.
10. Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 2008; 9:283-302.
11. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673-680.
12. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62:417-426.
13. Milewicz DM, Grossfield J, Cao SN, Kielty C, Covitz W, Jewett T. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 1995; 95:2373-2378.
14. von Kodolitsch Y, Rybczynski M, Detter C, Robinson PN. Diagnosis and management of Marfan syndrome. Future Cardiol 2008; 4:85-96.
15. Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA 1989; 262:523-528.
16. Devereux RB, Kramer-Fox R, Shear MK, Kligfield P, Pini R, Savage DD. Diagnosis and classification of severity of mitral valve prolapse: methodologic, biologic, and prognostic considerations. Am Heart J 1987; 113:1265-1280.
17. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989;5:303-311; discussion 312-313.
18. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64:507-512.
19. Biaggi P, Matthews F, Braun J, Rousson V, Kaufmann PA, Jenni R. Gender, age, and body surface area are the major determinants of ascending aorta dimensions in subjects with apparently normal echocardiograms. J Am Soc Echocardiogr 2009; 22:720-725.
20. Levey AS, Bosch J P, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
21. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002; 15:445-452.
22. Rommel K, Karck M, Haverich A, von Kodolitsch Y, Rybczynski M, Müller G, Singh KK, Schmidtke J, Arslan-Kirchner M. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat 2005; 26:529-539.
23. Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat 2006; 27:770-777.
24. Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 2008; 51:701-707.
25. Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977; 39:13-20.
26. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 1984; 53:849-855.
27. Ueda T, Shimizu H, Aeba R, Shin H, Katogi T, Yozu R, Kawada S. Prognosis of Marfan and non-Marfan patients with cystic medial necrosis of the aorta. Jpn J Thorac Cardiovasc Surg 1999; 47:73-78.
28. Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK. Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 2009; 33:194-201.
29. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46:1753-1760.
30. Yetman AT, Beroukhim RS, Ivy DD, Manchester D. Importance of the clinical recognition of Loeys-Dietz syndrome in the neonatal period. Pediatrics 2007; 119:e1199-e1202.
31. Viassolo V, Lituania M, Marasini M, Dietz H, Benelli F, Forzano F, Faravelli F. Fetal aortic root dilation: a prenatal feature of the Loeys-Dietz syndrome. Prenat Diagn 2006; 26:1081-1083.
32. Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, Kalra M, Sullivan T, Gloviczki P. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005; 42: 98-106.
33. Nistri S, Grande-Allen J, Noale M, Basso C, Siviero P, Maggi S, Crepaldi G, Thiene G. Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J 2008; 29:472-479.
34. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 2000; 102:III35-III39.
35. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A; Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-268.
36. Peters K F, Horne R, Kong F, Francomano CA, Biesecker BB. Living with Marfan syndrome II. Medication adherence and physical activity modification. Clin Genet 2001; 60:283-292.